神经母细胞瘤的视网治疗:历史概述,监管挑战和前景
Atsushi Makimoto1,2,3, Hiroyuki Fujisaki4, Kimikazu Matsumoto5
1Department of Laboratory Medicine, Tokyo Metropolitan Children's Medical Center, Fuchu 183-8561, Japan.
Cancers
|February 10, 2024
概括
视网类药物治疗,特别是异类药物治疗,对高风险神经母细胞瘤显示出有前途. 一项新的临床试验旨在支持其作为标准治疗的使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 视网类药物,维生素A衍生物,在神经母细胞瘤治疗方面有着悠久的历史.
- 伊索特里诺因在高风险神经母细胞瘤患者中显示出改善无事件生存的潜力.
- 目前在美国和欧盟使用异二因的非标签使用需要进一步的临床验证.
研究的目的:
- 审查神经母细胞瘤中视网类药物治疗的科学基础和临床证据.
- 在日本推出一项计划的研究人员发起的异丁临床试验.
- 讨论神经母细胞瘤视网类药物治疗的未来前景.
主要方法:
- 审查现有的关于视网体和神经母细胞瘤的科学文献.
- 分析临床前和临床数据,支持视网类药物的疗效.
- 拟议的研究人员发起的,注册导向的临床试验设计概要.
主要成果:
- 视网类药物治疗,特别是异类药物治疗,在高风险神经母细胞瘤的无事件生存率上有~10%的改善.
- 伊索特里诺因是神经母细胞瘤管理的关键组成部分,尽管在某些地区的标签之外的地位.
- 拟议的试验旨在收集数据,以便在日本获得监管批准.
结论:
- 视网类药物治疗,以异黄类药物作为先驱,对神经母细胞瘤具有显著的治疗潜力.
- 进一步的临床试验至关重要,以确定异氨酸作为标准的,批准的治疗.
- 这项研究支持在儿科瘤学中推进基于视网体的策略.
关键词:
这是一个高风险的高风险项目.这是一种异氨酸 (isotretinoin).维护疗法维护疗法神经母细胞瘤的神经母细胞瘤标签之外的问题网红素酸是什么 网红素酸是什么视网类药物治疗视网类药物 视网类药物瘤分化疗法是一种瘤分化疗法.更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
